Tobacco use contributes 48.7% of cancer among males: ICMR

admin November 9, 2021
Updated 2021/11/09 at 11:30 AM

Males (52.4%) had more cancer cases than females (47.4%), with gynaecological cancers, such as breast cancer, accounting for more than half of all cancers in women. According to the Indian Council of Medical Research’s (ICMR) ‘Clinicopathological Profile of Cancers in India: A Report of the Hospital Based Cancer Registries, 2021,’ childhood cancers account for 7.9% of all cancers.

According to the study, cancers of the head and neck area accounted for almost a third of all cancers in men (31.2 percent). With the exception of prostate cancer in men, which was greater in those over 65 years, the 45 to 64 year age group had the greatest percentage of cancer from all sites.

During 2012-19, the National Cancer Registry Programme (NCRP) recorded 13,32,207 cancer cases from 96 hospitals, according to the study. Based on the completeness and quality of data, a total of 6,10,084 cases were chosen for study.

According to the study, 3,19,098 cancers (52.4% ) were recorded in men and 2,90,986 cancers (47.6% ) in females out of a total of 6,10,084 cancers. Males had 48.7% of cancers in areas linked to tobacco use, while females had 16.5 percent.

“With the exception of thyroid cancer (2.5 percent in girls vs 1 percent in men) and gallbladder cancer (3.7 percent in females versus 2.2 percent in males),” the study says, “the relative percentage of site-specific cancers was greater in males than females.”

According to the study, almost a third of patients with tongue, laryngeal, thyroid, corpus uteri, kidney (including children), bladder, and retinoblastoma had localised illness at the time of presentation.

“Regardless of the clinical extent of disease at presentation, chemotherapy was the most common treatment modality for many cancers, including cancers of the liver, gallbladder, stomach, lung, and childhood cancers, and regardless of the organ site or clinical extent, most cancer patients were started on cancer-directed treatment within 8 to 30 days of diagnosis,” the report states.

Furthermore, more than half of patients with brain and nervous system cancer, as well as approximately a third of patients with lung, prostate, bladder, and thyroid cancer with localised illness identified at the reporting institution, were started on cancer focused therapy the same day.


Source: The Hindu

Share this Article
Leave a comment

Leave a Reply

Your email address will not be published.